Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Cloud-based digital pathology platform helps CRO deliver more informed preclinical studies

By Heather Hall | April 24, 2023

Proscia, a provider of digital and computational pathology solutions, has announced that Virscio, a provider of translational research and development services, has deployed Concentriq for Research. The contract research organization (CRO) is leveraging Proscia’s flagship software platform to provide faster, more informed drug safety insights, helping its sponsors to improve research and development (R&D) efficiency.

90% of drug candidates fail during clinical trials.[1] This negatively impacts R&D efficiency, as measured by the number of new drugs approved relative to investment. Effective preclinical development hinges on accurate and high throughput evaluation of large volumes of pathology data to define the safety of a candidate before it can move on to human clinical trials. As such, Virscio recognized that optimizing its pathology operations by adopting Concentriq for Research would enable its sponsors to more rapidly and confidently advance lead programs and get therapeutic breakthroughs to patients sooner.

Concentriq is trusted by 14 of the top 20 pharmaceutical companies and leading CROs to drive quality and productivity gains across the R&D value chain. Virscio is leveraging the scalable, cloud-based platform to unify its teams and data across Good Laboratory Practice (GLP) and non-regulated studies, streamlining collaboration among its distributed scientists, sponsors, and external collaborators. The platform also offers world-class interoperability with leading image analysis and artificial intelligence (AI) applications, allowing Virscio’s scientists to unlock new insights that further inform decision-making.

“Translating concept to clinical success requires innovative technology, and we’ve found this in Concentriq for Research,” said Matthew Lawrence, M.D., Ph.D., Virscio’s CEO. “The platform enables us to see through our transformative approach to preclinical development and create added value for our teams and sponsors.”

With today’s news, Virscio joins other life sciences organizations at the forefront of digital pathology adoption. Concentriq for Research augments its integrated in-life and histology capabilities and unparalleled access to highly translational in vivo models that truly predict risk and response to meet the expanding demands of the biotechnology and pharmaceutical companies it serves. In turn, Virscio is further positioned to overcome lengthening drug development timelines and reduce development costs; the average drug takes 10 to 15 years and costs $2.6 billion to bring to market.[2]

“We are excited to welcome Virscio to the growing roster of organizations turning to Concentriq for Research to accelerate therapeutic innovation,” said David West, Proscia’s CEO. “Virscio is driving forward a new era of preclinical development, and we look forward to seeing the impact of digital pathology in addressing the critical challenge of R&D efficiency.”

[1] Sun, D. et al (2022, July). Why 90% of clinical drug development fails and how to improve it? Acta Pharmaceutica Sinica B. 12 (7). Retrieved April 19, 2023, from https://doi.org/10.1016/j.apsb.2022.02.002

[2] Pharmaceutical Researchers and Manufacturers of America. (2021, September 30). Research & Development Policy Framework. PhRMA Org. Retrieved April 19, 2023, from https://phrma.org/policy-issues/Research-and-Development-Policy-Framework

Related Articles Read More >

Replacing animal models? Silk sponge 3D cell culture system shows high potential for cancer diagnostics and drug screening
Japanese drug shows promise in preventing COVID-19 infection
8 major R&D moves this week: Roche/Genentech moves to Harvard, TSMC invests $100B, ThyssenKrupp cuts jobs and more
7 major R&D moves this week: Apple expands U.S. manufacturing, Lilly plans new plants, tech giants advance in computing
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE